Kraig Biocraft Laboratories (KBLB) Stock Statistics & Valuation Metrics

Kraig Biocraft Laboratories has a market cap or net worth of $94.80M. The enterprise value is $121.19M.

Kraig Biocraft Laboratories has 1,115,334,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Kraig Biocraft Laboratories’s return on equity (ROE) is 0.45 and return on invested capital (ROIC) is 53.27%.

The current PE Ratio of Kraig Biocraft Laboratories is ―. Kraig Biocraft Laboratories’s PEG ratio is -8.30.

In the last 12 months, Kraig Biocraft Laboratories had revenue of 0.00 and earned -3.62M in profits. Earnings per share was >-0.01.

In the last 12 months, operating cash flow was -1.79T and capital expenditures -5.40B, giving a free cash flow of -1.79T billion.

Kraig Biocraft Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―

Kraig Biocraft Laboratories upcoming earnings date is Aug 10, 2023, After Close (Confirmed).

Kraig Biocraft Laboratories as a current ratio of 0.18, with Debt / Equity ratio of -2.87%

In the past 12 months, Kraig Biocraft Laboratories has paid 0.00 in taxes.

Kraig Biocraft Laboratories EV to EBITDA ratio is -29.88, with an EV/FCF ratio of -50.41.

Kraig Biocraft Laboratories has $3.39M in cash and marketable securities with $194.01K in debt, giving a net cash position of $3.20M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Kraig Biocraft Laboratories is ―, which is 11.43% higher than the current price. The consensus rating is ―